ARCHIVES

Individualized Cancer Vaccines Show 90% Survival at 6 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCA Declines To Set Minimum Comp Center Bed Number

April 2, 1976

Zydelig Tablets Approved For Three Blood Cancers

July 25, 2014

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

July 31, 2009

Centers Ask Americans for $1 Each for Research.

May 16, 2008

NCI To Support Chemoprevention Grants In Tobacco-Related Cancer, Ex-Smokers.

March 16, 2001

Letter to the Editor: A Victory for Research, But Real Work Is Ahead

November 26, 1999